Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
InterCure (INCR)
NASDAQ:INCR
Holding INCR?
Track your performance easily
INCR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.17 - $3.72
Previous Close$1.42
Volume18.29K
Average Volume (3M)32.44K
Market Cap
$63.28M
Enterprise Value$155.13M
Total Cash (Recent Filing)₪101.14M
Total Debt (Recent Filing)₪191.04M
Price to Earnings (P/E)10.8
Beta1.46
Next Earnings
Apr 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.13
Shares Outstanding45,572,689
10 Day Avg. Volume80,793
30 Day Avg. Volume32,439
Standard Deviation0.50
R-Squared0.04
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.13
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Intercure News
PremiumCompany Announcements
Intercure Ltd. Files SEC Report, Ensures Transparency
PremiumCompany Announcements
Intercure Ltd. Files April SEC Report
PremiumCompany Announcements
Intercure Ltd. Submits SEC Compliance ReportOwnership Overview
―
Insiders
0.04% Mutual Funds
4.90% Other Institutional Investors
94.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INCR FAQ
What was InterCure’s price range in the past 12 months?
InterCure lowest stock price was $1.17 and its highest was $3.72 in the past 12 months.
What is InterCure’s market cap?
Currently, no data Available
When is InterCure’s upcoming earnings report date?
InterCure’s upcoming earnings report date is Apr 07, 2025 which is in 131 days.
How were InterCure’s earnings last quarter?
Currently, no data Available
Is InterCure overvalued?
According to Wall Street analysts InterCure’s price is currently Overvalued.
Does InterCure pay dividends?
InterCure does not currently pay dividends.
What is InterCure’s EPS estimate?
InterCure’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InterCure have?
InterCure has 45,765,420 shares outstanding.
What happened to InterCure’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InterCure?
Currently, no hedge funds are holding shares in INCR
---
Intercure Stock Smart Score
Company Description
InterCure
Intercure Ltd is a medical company that sells FDA-cleared, non-drug, non-invasive hypertension treatment device RESPeRATE that helps lower blood pressure using paced breathing.
---
INCR Earnings Call
Q4 2023
0:00 / 0:00
---
INCR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering INCR
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-56.80%
initiated a buy rating 6 months ago
Copying Pablo Zuanic's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -56.80% per trade.
---